SHARE Metastatic Breast Cancer
1,434 members752 posts

KISQALI Is Now FDA Approved

Approved Use:

KISQALI® (ribociclib) is a prescription medicine used in combination with a certain type of medicine as the first hormonal-based therapy to treat women who have gone through menopause with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negati... See More

us.kisqali.com/metastatic-b...

7 Replies
oldestnewest

I start this in a couple of weeks.

Reply

The drug has proved to be very successful in treatment of stage IV breast cancer Hoping that it proves to be a total success

1 like
Reply

Thank you. After being stage 4 and taking arimidex i was stable for 3 years, now I have a walnut size active cancer in my upper right lung again. I dont do well when meds lower my counts. Ibrance sent me into neutropenia, extreme fatigue, stomatitis and pneumonitis to name a few SE's. I hope Kisqale is easier on my body.

2 likes
Reply

Missy , keep us informed. Can't wait to hear this new story. Happy for you

1 like
Reply

Thank you, i will!

1 like
Reply

I heard about this thru the San Antonio conference. This is very exciting. Another Ibrance like drug. Similar in the new way that it works and in the results

1 like
Reply

I believe that they are claiming that Kisqale doesn't effect your white blood count so much

2 likes
Reply

You may also like...